Orum Therapeutics, Inc.
Developing degrader-antibody conjugates for cell-selective protein degradation to treat cancer.
475830 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 문지로 281-25, 대전광역시
- Website:
- https://www.orumrx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Orum Therapeutics, Inc. is a clinical-stage biotechnology company pioneering a novel class of therapeutics using its proprietary TPD²® platform for cell-selective degradation. This technology combines the power of targeted protein degraders with the precision of antibodies to create degrader-antibody conjugates (DACs). The company's approach is designed to improve upon the efficacy, safety, and half-life of conventional protein degraders. Orum is focused on building a portfolio of highly differentiated products to treat diseases with high unmet medical needs, including cancer, by expanding the landscape of druggable targets.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-29 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 348.3 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.1 MB | ||
| 2025-08-08 00:00 |
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
|
Korean | 382.4 KB | ||
| 2025-08-08 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 339.8 KB | ||
| 2025-08-01 00:00 |
Post-Annual General Meeting Information
임시주주총회결과
|
Korean | 10.7 KB | ||
| 2025-08-01 00:00 |
Remuneration Information
주식매수선택권부여에관한신고
|
Korean | 21.5 KB | ||
| 2025-07-25 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 368.6 KB | ||
| 2025-07-17 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 77.7 KB | ||
| 2025-07-10 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
|
Korean | 16.8 KB | ||
| 2025-06-25 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 10.7 KB | ||
| 2025-06-25 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.2 KB | ||
| 2025-06-04 00:00 |
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
|
Korean | 372.2 KB | ||
| 2025-06-04 00:00 |
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
|
Korean | 360.6 KB | ||
| 2025-05-26 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2025-05-22 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.7 KB |
Automate Your Workflow. Get a real-time feed of all Orum Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Orum Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
